Cellectis SA (CLLS)
3.57
+0.07
(+2.00%)
USD |
NASDAQ |
Feb 06, 16:00
3.60
+0.03
(+0.84%)
After-Hours: 20:00
Cellectis SG&A Expense (TTM) : 19.93M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| EDAP TMS SA | 43.50M |
| DBV Technologies SA | 28.71M |
| Ascendis Pharma A/S | 446.44M |
| Akari Therapeutics Plc | 10.20M |
| Biodexa Pharmaceuticals Plc | 5.354M |